Finance

Lists
ANL:NASDAQ
Adlai Nortye Ltd
$13.25
+3.03%
(+0.39) 1D
Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANL...
Open
$12.73
High
$13.32
Low
$12.62
Mkt. cap
1.04B
Avg. vol.
222.46K
Volume
56.29K
52-wk high
$17.25
52-wk low
$0.88
EPS
-$1.11
Shares outstanding
72.86M
No. of employees
109
Open
$12.73
High
$13.32
Low
$12.62
Mkt. cap
1.04B
Avg. vol.
222.46K
Volume
56.29K
52-wk high
$17.25
52-wk low
$0.88
EPS
-$1.11
Shares outstanding
72.86M
No. of employees
109
News stories
From web sources and news partners
About Adlai Nortye Ltd
CEO-
Employees109
Founded2004
Headquarters-
SectorBiotechnology
Websiteadlainortye.com
Analyst ratings
Based on 4 analysts giving stock ratings to ANL in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ANL in the last 3 months.
Highest
Current $13.25
$32.00 (+141.51%)
Average
$24.67 (+86.19%)
Lowest
$20.00 (+50.94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
$22.00
+66%
08/14/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$20.00
+50.9%
08/14/2026
Lina Kaminski
JonesTrading
Buy
Maintained
$22.00
+66%
07/16/2026
Li Watsek
Cantor Fitzgerald
Buy
Maintained
-
-
07/16/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$28.00
+111.3%
06/22/2026
Jay Olson
Oppenheimer
Buy
Initiated
$32.00
+141.5%
05/28/2026
Andrew Berens
Leerink Partners
Buy
Initiated
$23.00
+73.6%
03/20/2026
Christopher Liu
Lucid Capital
Buy
Initiated
$11.00
-17%
01/29/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
2.50M
2.50M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.62M
7.62M
8.79M
8.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.03M
2.03M
2.10M
2.10M
Operating expense
9.59M
9.59M
10.76M
10.76M
Total operating expenses
9.59M
9.59M
10.76M
10.76M
Operating income
-9.59M
-9.59M
-8.26M
-8.26M
Other non operating income
730.50K
730.50K
99.50K
99.50K
EBT including unusual items
-9.17M
-9.17M
-8.60M
-8.60M
EBT excluding unusual items
-9.17M
-9.17M
-8.60M
-8.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-70.00K
-70.00K
-128.00K
-128.00K
Net income
-9.17M
-9.17M
-8.60M
-8.60M
Net profit margin
-
-
-343.86%
-343.86%
Earnings per share
-
-
-
-
Interest and investment income
49.00K
49.00K
-
-
Interest expense
-358.00K
-358.00K
-434.50K
-434.50K
Net interest expenses
-309.00K
-309.00K
-434.50K
-434.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.34M
-9.34M
-8.01M
-8.07M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps